Second-Quarter Consumer Health Results Bring J&J Relief From Year-Ago Sales Plummet
Segment's Results Likely Better Than Remainder Of 2021, J&J And Analyst Say
Executive Summary
In first of what could be similar April-June earnings results from major consumer health firms, J&J reports 9.2% operational growth to $3.74bn in sales. Worldwide consumer health chief Thibaut Mongon touts segment’s results and outlook but says similar growth in second half isn’t assured.
You may also be interested in...
J&J Consumer Health Sees Pandemic Accelerate Shift To Digital
J&J Consumer Health's worldwide chairman Thibaut Mongon told the recent Barclays Consumer Staples conference that COVID-19 had accelerated the shift to digital and what consumers expect from OTC brands.
J&J's CEO Gorsky Steps Aside With Duato Named His Successor
J&J's CEO Alex Gorsky is stepping down after almost 10 years in the role and will be replaced by vice chairman of the executive committee Joaquin Duato.
J&J CEO Gorsky Handing Over The Reins To Vice Chairman Duato
Duato has been involved for the last several years in growing J&J’s pharma and consumer businesses and has led the company’s COVID-19 efforts. Gorsky is stepping down due to a family health issue.